A recently published study, “Hyperbaric Oxygen Therapy Can Diminish Fibromyalgia Syndrome – Prospective Clinical Trial,” conducted  by doctors in Tel-Aviv, Israel produced confirmation to many U.S. doctors’ observations that hyperbaric oxygen therapy is effective in the treatment of fibromyalgia.  Patients were randomly assigned to treated and crossover groups: The treated group patients were evaluated at baseline and after HBOT. Patients in the crossover-control group were evaluated three times: baseline, after a control period of no treatment, and after HBOT. Evaluations consisted of physical examination, including tender point count and pain threshold, extensive evaluation of quality of life, and single photon emission computed tomography (SPECT) imaging for evaluation of brain activity. The HBOT protocol comprised 40 sessions, 5 days/week, 90 minutes, 100% oxygen at 2ATA. Sixty female patients were included, aged 21–67 years and diagnosed with fibromyalgia syndrome at least 2 years earlier. HBOT in both groups led to significant decrease of all fibromyalgia symptoms, with significant improvement in life quality. Analysis of SPECT imaging revealed rectification of the abnormal brain activity: decrease of the hyperactivity mainly in the posterior region and elevation of the reduced activity mainly in frontal areas.  The study can be found in its entirety at PLOS One (a peer-reviewed open access scientific journal) by clicking here.

Related Posts